Agenda

General Downloads

Day 1: Thursday 29th September 2011 (09:00 – 19:00)

8:00 – 9:00 Registration and coffee (at the Aula)

Morning session 09:00 – 12:00

Chair: Hans Hogerzeil

At the Festsaal
09:00 – 09:30 Welcome
  • Austrian Ministry of Health (BMG), Minister Alois Stöger
  • Austrian Health Institute (GÖG), General Manager Georg Ziniel
  • Austrian Health Institute (GÖG), Head of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Sabine Vogler
  • World Health Organization Regional Office for Europe, Regional Adviser Health, Technology and Pharmaceuticals, Kees de Joncheere
09:30 – 10:30 Pharmaceutical policies in a changing world – key statements from players in pharmaceutical systems
Chair: Hans Hogerzeil
  • Kees de Joncheere, World Health Organization Regional Office for Europe
  • Regina Skavron, Medicines Department, German Federal Joint Committee (Gemeinsamer Bundesausschuss)
  • Richard Bergström, Director General of the European Federation of Pharmaceutical Industries (EFPIA) and Head of the Swedish Association of the Pharmaceutical Industry (LIF)
  • Elizabeth Docteur, Elizabeth Docteur Consulting, USA
10:30 – 11:00 Coffee break (at the Aula)
11:00 – 12:00 Key note presentation – Solidarity and innovation
Erik Schokkaert, Department of Economics, K.U. Leuven
Downloaddownload arrow
12:00 – 13:00 Lunch (at the Aula)

Afternoon session 13:00 – 17:30 – European perspective

Parallel sessions

At the Festsaal At the Sitzungssaal
(number of participants is limited!)
At the Theatersaal
(opposite the venue location at Sonnenfelsgasse 19)
13:00 – 14:30 Pricing and reimbursement policies in the light of the financial crisis
Chair: Kees de Joncheere, WHO Regional Office for Europe
The hospital setting as key sector - Interface management
Chair: Roberto Frontini, European Association of Hospital Pharmacists
How to interpret and compare pharmaceutical prices
Chairs: Claudia Habl, Bettina Schmickl, GÖG
  • Policy monitoring (Richard Laing, WHO Headquarters)
  • Pharmaceutical policies in response to the financial crisis (Sabine Vogler, WHO CC, GÖG) Downloaddownload arrow
  • Country examples:
    • Ireland (Kate Mulvenna, Health Service Executive) Downloaddownload arrow
    • Portugal (Miguel Gomes, INFARMED) Downloaddownload arrow
  • International experiences (Anita Wagner, Harvard Medical School and Harvard Pilgrim Health Care Institute, USA) Downloaddownload arrow
  • Results and outcomes of a hospital survey - PHIS (Jan Mazag, State Institute for Drug Control, SUKL, SK) Downloaddownload arrow
  • The Swedish example (Rickard Malmström, Karolinska Hospital) Downloaddownload arrow
  • The Scottish example (Ken Paterson, Scottish Medicines Consortium) Downloaddownload arrow
  • The Norwegian example (Øyvind Melien, Norwegian Directorate of Health) Downloaddownload arrow
  • Price comparison:
    • Price types and levels (Bettina Schmickl, GÖG) Downloaddownload arrow
    • Hospital price survey PHIS (Nina Zimmermann, GÖG) Downloaddownload arrow
  • European experiences with price comparisons:
    • Czech experiences (Lenka Vostalová, State Institute for Drug Control, SUKL, CZ) Downloaddownload arrow
    • Company perspecitve (Irma van den Arend, Ipsen Pharma SAS, France) Downloaddownload arrow
14:30 – 15:00 Coffee break (at the Aula)
15:00 – 16:30 Pharmaceutical pricing policies
Chair: Elizabeth Docteur, Elizabeth Docteur Consulting, USA
Experiences with pharmaceutical profiles
Chair: Nina Zimmermann, GÖG
Commercial aspects of rational use
Chair: Richard Laing, WHO Headquarters
  • Comparison of prices (Valérie Paris, OECD) Downloaddownload arrow
  • External price referencing (Christine Leopold, GÖG) Downloaddownload arrow
  • Internal price referencing (Jaime Espin, Andalusian School of Public Health) Downloaddownload arrow
  • A common language (Sabine Vogler, WHO CC GÖG) Downloaddownload arrow
  • WHO experiences (Gilles Forte, WHO Headquarters) Downloaddownload arrow
  • Experiences from the Global Fund (Luca Li Bassi, The Global Fund to Fight AIDS, Tuberculosis and Malaria) Downloaddownload arrow
  • Consumer view (Margaret Ewen, Health Action International) Downloaddownload arrow
  • Payers view (Ad R. Schuurman, Health Care Insurance Board (NL)) Downloaddownload arrow
  • Company view (Richard Bergström, EFPIA) Downloaddownload arrow
  • Pharmacist view (John Chave, Pharmaceutical Group of the European Union (PGEU), Belgium) Downloaddownload arrow

Plenary session

At the Festsaal
16:40 – 17:30 Key note presentation - Access to High Cost Medicines, examples from the Americas
Alexandre Lemgruber, The Pan American Health Organisation
Downloaddownload arrow
17:30 – 19:00 Reception at the Aula (open to all participants)

Day 2: Friday 30th September 2011 (08:00 – 16:00)

Satellite session 08:00 – 08:45 (participation optional)

At the Theatersaal
08:00 – 08:45 Meet editors of journals in the pharmaceutical field – question and answer session

Morning session 09:00 – 13:00

Chair: Claudia Habl (WHO CC, GÖG)

At the Festsaal
09:00 – 09:40 Pricing and reimbursement of medicines – a European overview
Sabine Vogler, GÖG Downloaddownload arrow
09:50 – 11:00 Parallel poster sessions: Presentations of country examples of pharmaceutical systems
At the Festsaal At the Theatersaal
(opposite the venue location at Sonnenfelsgasse 19)
At the Sitzungssaal At the Aula
Western and Nordic countries
Chair: Sveinbjörn Högnason, Icelandic Medicine Pricing and Remibursement Committee
Central and Eastern Europe
Chair: Jan Mazag, SUKL Slovakia
Mediterranean countries (incl. FR)
Chair: Miguel Gomes, INFARMED Portugal
World perspective
Chair: Joan Rovira, Barcelona University, Spain
09:50 – 10:05 Germany (Silke Baumann, Ministry of Health) Downloaddownload arrow Latvia (Janis Innus, Centre of Heath Economics) Downloaddownload arrow France (Sophie Lopes, CNAMTS) Downloaddownload arrow
10:05 – 10:20 United Kingdom (David Kullmann, Department of Health) Downloaddownload arrow Poland (Jakub Adamski, Ministry of Health) Downloaddownload arrow Greece (Lena Katsomiti, Greek Ministry of Health) Downloaddownload arrow
10:20 – 10:35 Finland (Jaana Martikainen, The Social Insurance Institution) Downloaddownload arrow Hungary (Judit Bidló, National Health Insurance Dund Administration) Downloaddownload arrow Spain (Piedad Ferre, Ministry of Health) Downloaddownload arrow
10:35 – 11:00 Discussion on differences and similarities Discussion on differences and similarities Discussion on differences and similarities
Coffee break (at the Aula)
11:30 – 13:00 Parallel abstract presentations and poster session
At the Festsaal At the Sitzungssaal At the Theatersaal
(opposite the venue location at Sonnenfelsgasse 19)
Pricing and reimbursement of medicines
Chairs: Jaime Espin, Andalusian School of Public Health (EASP), Christine Leopold, GÖG
Hospital pharma - Interface management
Chairs: Øyvind Melien, Norwegian Directorate of Health, Ján Mazag, SUKL - State Institute for Drug Control, Slovakia
Rational use of medicines
Chairs: Aukje Mantel-Teeuwisse, Utrecht University, Anita Wagner, WHO CC Boston University
11:30 – 11:45 Abstract # 85:
Cost containment interventions introduced on the community drug schemes in Ireland - evaluation of expenditure trends using a national prescription claims database.
(Cara Usher, National Centre for Pharmacoeconomics, Ireland)
Downloaddownload arrow
Abstract # 67
Enhancing the utilisation of generic clopidogrel: a case history for future guidance?
(Christoph Baumgaertel, AGES PharmMed, Austrian Medicines and Medical Devices Agency, and Kristina Garuoliené, National Health Insurance Fund under the Ministry of health of the Republic of Lithuania)
Downloaddownload arrow
The need for generic policies as part of health reform
(Richar Laing, WHO Headquarters)
Downloaddownload arrow
11:45 - 12:00 Abstract # 91
Income Concentration and Price Differentiation in Low and Middle Income Pharmaceutical Markets
(Eric L. Keuffel, Fox School of Business (Temple University), USA)
Downloaddownload arrow
Abstract # 96
Influence of hospital choices of competitive drugs on the pharmaceutical consumption in the community
(Adeline Gallini, University of Toulouse, France)
Downloaddownload arrow
Abstract # 56
Potential methods to enhance prescribing efficiency, implications for sustaining healthcare systems
(Brian Godman - Division of Clinical Pharmacology, Karolinska Institutet, Sweden, Prescribing Research Group, Liverpool University, UK)
Downloaddownload arrow
12:00 - 12:15 Abstract # 64
Performance of drug reimbursement systems: a comparison of the Austrian, Belgian, Dutch, French and Swedish systems
(Margreet Franken, Institute for Health Policy and Management, Erasmus University Rotterdam, The Netherlands)
Downloaddownload arrow
Abstract # 52
Do European rheumatoid arthritis patients have equal access to treatment with new medicines?
(Joëlle M. Hoebert, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands)
Downloaddownload arrow
Health Care and Medicines Need and Access: Are there Gender Inequities?
(Anita Wagner, Harvard Medical School and Harvard Pilgrim Health Care institute, USA)
Downloaddownload arrow
12:15 - 12:30 Poster presentations

Prices and affordability of medicines in Armenia (Margit Melikyan, Drug Utilisation Research Group Armenia)
Downloaddownload arrow

Access to innovative anticancer drugs in the outpatient setting in Latvia (Marta Kipena, The Centre of Health Economics, Latvia)
Downloaddownload arrow

Development of benchmarks to improve price negotiations of antiretroviral medicines for low and middle iincome countries (Veronika Wirtz, National Institute of Public Health, Mexicao)
Downloaddownload arrow

Poster presentations

Characteristics of medicines management in Austrian hospitals (Elfriede Dolinar, Vienna General Hospital, Austria)
Downloaddownload arrow

Access to high cost medicines: a systematic review of the literature (Philip Wahlster, University of Auckland, University of Greifswald, Germany)
Downloaddownload arrow

Poster presentations

Report Cards on Prescribing Behavior: Assessing the Impacts of Public Disclosure on Antibiotic Prescribing Rate (Seemoon Choi, Department of Global Health and population, Harvard School of Public Health, USA)
Downloaddownload arrow

High rate of self purchasing of oral antibiotics in Serbia: implications for future policies (Marija Kalaba, Republic Institute for Health Insurance, Republic of Serbia)
Downloaddownload arrow

Essential to review health policy initiatives when comparing utilisation patterns across countries? (Brian Godman, Division of Clinical Pharmacology. Karolinska Institute, Sweden Presribing Research Group, Liverpool University, UK)
Downloaddownload arrow

12:30 - 13:00 Poster walk
13:00 – 14:00 Lunch (at the Aula)

Afternoon session 14:00 – 16:00

Chair: Sabine Vogler, GÖG

At the Festsaal
14:00 – 14:45 Key note presentation - Pricing and reimbursement of medicines from global perspective
Andreas Seiter, World Bank
Downloaddownload arrow
14:45 – 15:45 Panel discussion: The way forward - reflections and future directions
Chair: Sabine Vogler, GÖG
  • Valérie Paris, OECD
  • Anita Wagner, WHO CC Boston University/Harvard
  • Øyvind Melien, Norwegian Directorate of Health
  • Aarti Patel, Representative of Southern African Development Community
  • Karin Kadenbach, Member of the European Parliament, Austria
  • Hans Kluge, Director, Health Systems and Public Health, WHO Europe
15:45 – 16:00 Closing addresses
Karin Kadenbach, Member of the European Parliament, Austria
Sabine Vogler, WHO CC, Austrian Health Institute - GÖG